Showing 10,661 - 10,680 results of 226,405 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((largest decrease) OR (greater decrease)) ))', query time: 1.13s Refine Results
  1. 10661

    Data_Sheet_2_Associations of the miRNA-146a rs2910164 and the miRNA-499a rs3746444 Polymorphisms With Plasma Lipid Levels: A Meta-Analysis.doc by Fuqiang Liu (451879)

    Published 2021
    “…The standardized mean difference (SMD) and 95% confidence interval (CI) were used to evaluate the differences in lipid levels between the genotypes. rs2910164, a functional polymorphism in the miRNA-146a gene, was associated with increased triglycerides (TG) (SMD = 0.35, 95% CI = 0.15–0.54, p < 0.001), total cholesterol (TC) (SMD = 0.43, 95% CI = 0.16–0.70, p < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = 0.37, 95% CI = 0.11–0.63, p = 0.01) as well as decreased high-density lipoprotein cholesterol (HDL-C) (SMD = −0.27, 95% CI = −0.47−0.07, p = 0.01) levels. rs3746444, a functional polymorphism in the miRNA-499a gene, was only correlated with decreased TG (SMD = −0.09, 95% CI = −0.17−0.01, P = 0.03) levels.…”
  2. 10662

    Data_Sheet_1_Associations of the miRNA-146a rs2910164 and the miRNA-499a rs3746444 Polymorphisms With Plasma Lipid Levels: A Meta-Analysis.docx by Fuqiang Liu (451879)

    Published 2021
    “…The standardized mean difference (SMD) and 95% confidence interval (CI) were used to evaluate the differences in lipid levels between the genotypes. rs2910164, a functional polymorphism in the miRNA-146a gene, was associated with increased triglycerides (TG) (SMD = 0.35, 95% CI = 0.15–0.54, p < 0.001), total cholesterol (TC) (SMD = 0.43, 95% CI = 0.16–0.70, p < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = 0.37, 95% CI = 0.11–0.63, p = 0.01) as well as decreased high-density lipoprotein cholesterol (HDL-C) (SMD = −0.27, 95% CI = −0.47−0.07, p = 0.01) levels. rs3746444, a functional polymorphism in the miRNA-499a gene, was only correlated with decreased TG (SMD = −0.09, 95% CI = −0.17−0.01, P = 0.03) levels.…”
  3. 10663

    Placentome morphology and fetal weight. by Ellane R. Cleys (692077)

    Published 2015
    “…<p><b>A</b>) Testosterone propionate treatment (TP) decreased the number of type A placentomes, and increased type C and type D placentomes collected at gestational day 90. …”
  4. 10664
  5. 10665
  6. 10666
  7. 10667

    Lytic reactivation stimuli decrease Oct-2 expression. by Amanda R. Robinson (184305)

    Published 2012
    “…<p>(A) The EBV-negative B-cell line, Akata (-), and the EBV-positive B-cell line, Akata-EBV+, were lytically induced with anti-IgG (20 µg/mL). …”
  8. 10668

    The ω Subunit of RNA Polymerase Is Essential for Thermal Acclimation of the Cyanobacterium <i>Synechocystis</i> Sp. PCC 6803 by Liisa Gunnelius (658400)

    Published 2014
    “…<div><p>The <i>rpoZ</i> gene encodes the small ω subunit of RNA polymerase. A ΔrpoZ strain of the cyanobacterium <i>Synechocystis</i> sp. …”
  9. 10669

    RQ<sub>10</sub> and Q<sub>10</sub> production (pmol/mg wet pellet) in <i>R</i>. <i>rubrum</i> mutant strains from LC-MS analysis. by Amanda R. M. Campbell (6719102)

    Published 2019
    “…<p>A. Anaerobic growth conditions with RQ<sub>10</sub> production designated with dark grey bars and Q<sub>10</sub> with light grey bars. …”
  10. 10670
  11. 10671

    The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

    Published 2019
    “…<p>(A) Effect of Hsp90α ASO on cell viability. Differentiated SH-SY5Y cells were transfected with different concentrations of Hsp90α ASO. …”
  12. 10672
  13. 10673
  14. 10674

    Differential levels of epigenetic regulators with TP treatment. by Ellane R. Cleys (692077)

    Published 2015
    “…<p>Analysis of relative mRNA levels for genes regulating histone and DNA methylation and imprinting in ovine placentome tissue from real time PCR. <i>KDM4C</i> was decreased in type A placentomes from TP treated ewes compared to controls. …”
  15. 10675
  16. 10676

    EsA protected against GalN/LPS-induced histopathological damage and hepatic dysfunction. by Fang Zhang (197215)

    Published 2014
    “…Levels of AST and ALT increased obviously after GalN/LPS challenge, and which were significantly decreased with EsA treatment (n = 6 C). The values presented are the means ± standard error of the mean. …”
  17. 10677

    Summary of WetA functions and a model for WetA-mediated developmental regulation in <i>A</i>. <i>flavus</i>. by Ming-Yueh Wu (630764)

    Published 2017
    “…In this model, those genes with increased and decreased mRNA levels in the Δ<i>wetA</i> conidia are labeled in yellow (WetA-inhibited) and blue (WetA-activated), respectively. …”
  18. 10678
  19. 10679

    Expression levels of genes involved in glycolysis upon treatment with 10058-F4. by Muhammad Mushtaq (788834)

    Published 2015
    “…<p>Expression levels of a set of genes (<i>GLUTI</i>, <i>HK</i>, <i>LDHA</i>, <i>MCT4</i>, <i>PDK1</i>, <i>PGK1</i>, and <i>PKM2</i>) were assessed by Q-PCR after the treatment of cells with 100 μM of 10058-F4 for 4 h. …”
  20. 10680

    EsA protected against CCl<sub>4</sub>-induced histopathological damage and hepatic dysfunction. by Fang Zhang (197215)

    Published 2014
    “…However, AST and ALT levels did not markedly increase in mice treated with EsA alone, and AST and ALT levels were significantly decreased with EsA treatment. …”